Inventiva (IVA) Change in Acquisitions & Divestments (2021 - 2025)
Inventiva (IVA) recorded quarterly Change in Acquisitions & Divestments of -$28.0 million in Q2 2025, down 515.45% quarter-over-quarter from $6.7 million in Q4 2021.
Inventiva (IVA) Change in Acquisitions & Divestments (2021 - 2025) Analysis & Trends
Inventiva's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at -$28.0 million for Q2 2025.
- In Q2 2025, Change in Acquisitions & Divestments changed N/A year-over-year to -$28.0 million; the TTM figure through Jun 2025 stood at -$14.2 million (changed N/A YoY), while the FY2025 annual figure was -$133865.0, down 101.39% from the prior year.
- Change in Acquisitions & Divestments was -$28.0 million for Q2 2025 at Inventiva, down from $6.7 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $9.0 million in Q1 2021 to a low of -$28.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Inventiva | 8.52 Mn | -260.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -28.01 Mn |
| Jun 30, 2025 | -28.01 Mn |
| Dec 31, 2021 | 6.74 Mn |
| Dec 31, 2021 | 6.74 Mn |
| Jun 30, 2021 | -1.89 Mn |
| Jun 30, 2021 | -1.89 Mn |
| Mar 31, 2021 | 9.00 Mn |
| Mar 31, 2021 | 9.00 Mn |